Sign In
Last checked at 
2 Oct 2013 10:55
For immediate release | 2 October 2013 |
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, in the six months since the previous block admission update on 22 May 2013 the following changes have taken place:
Futura Medical plc Option Plan | Block Listed 25 May 2011 | Block Listing Brought Forward | Options Exercised in Period | Options Added to Block Listing In Period | Block Listing Carried Forward |
Unapproved Share Option Scheme | 814,424 | 684,155 | - | 1,193,959 | 1,878,114 |
EMI Share Option Scheme | 1,520,576 | 548,086 | (135,000) | 1,476,041 | 1,889,127 |
2,335,000 | 1,232,241 | (135,000) | 2,670,000 | 3,767,241 |
An application has been made to the London Stock Exchange for the block admission of a further 2,670,000 ordinary shares of 0.2p pence each ("Ordinary Shares") to be admitted to trading on AIM. The new shares expected to be admitted pursuant to the above application shall rank pari passu with the existing issued Ordinary Shares of the Company. It is expected that admission will become effective on 8 October 2013.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive
| Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Cenkos Securities plc |
|
Bobbie Hilliam | Tel:+44 (0)20 7397 8900 |
For media enquiries please contact: |
|
|
|
Buchanan |
|
Mark Court / Fiona Henson / Sophie Cowles | Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Follow the stocks
